Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

The identification and management of comorbidities are central to the care of patients with atrial fibrillation (AF). The ...

Inflammatory arthritis encompasses a group of autoimmune diseases, including rheumatoid arthritis (RA), psoriatic arthritis ...

In the new analysis of data from the SUMMIT trial, researchers focused on patients with obesity, chronic kidney disease and heart failure with preserved ejection fraction because they commonly have ...

Human Heat Tolerance Lower Than Previously Believed: Study FindsA study from the University of Ottawa’s Human and ...

Cardiac illnesses are among the trickier ones to manage in the limited time provided for many primary care visits, with ...

Findings presented at the American College of Cardiology Annual Scientific Session indicate that finerenone's efficacy in ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Severity of cardiometabolic comorbidity burden affects risk for all-cause hospitalization in patients with heart failure.